跳至主要内容
临床试验/IRCT201111108032N1
IRCT201111108032N1已完成2 期

Efficacy Of Losartan In Treatment Of Hyperuricemia After Renal Transplantation

Research Assistance Of Tabriz University Of Medical Science0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Post renal transplant patients; Normal and stable renal function; Completion of testimonial
  • Exclusion criteria: Transplanted renal artery stenosis; Acute rejection episode during last month; cardiovascular or cerebrovascular complications during last month or any abnormality in cardiac, lung or liver function; taking ACEIs , ARBs or any uric acid lowering agent and during study; more than 50% rise in serum creatinine; systolic blood pressure less than 90mmHg or diastolic blood pressure less than 60mmHg; Hb less than 100gr/

排除标准

  • 未提供

研究者

发起方
Research Assistance Of Tabriz University Of Medical Science

相似试验